1. Cohen AT, Alikhan R, Arcelus JI, et al. Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients. Thromb Haemost. 2005;94:750–9.
2. Bergmann J-F, Lloret-Linares C, Rami A, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): results obtained in France. Presse Med Paris Fr. 1983;2011(40):e528–37.
3. Sabroe JE. Madsen SM [Low molecular weight heparin as venous thromboembolism prophylaxis in hospitalized medical patients]. Ugeskr Laeger. 2016;178:2–5.
4. Rådet for Anvendelse af Dyr Sygehusmedicin. Baggrundsnotat for farmakologisk tromboseprofylakse til medicinske patienter.
http://www.rads.dk/media/2079/behrek-medicinske-patienter-2-0-224943_marts-2016.pdf
. Accessed 14 May 2017.
5. Spyropoulos AC, Anderson FA, FitzGerald G, et al. Predictive and associative models to identify hospitalized medical patients at risk for VTE. Chest. 2011;140:706–14.